IgE allergen component-based profiling and atopic manifestations in patients with Netherton syndrome - 02/10/14
![](/templates/common/images/mail.png)
Supported by Helsinki University Hospital Research funds (grant no. TYH2013235). |
|
Disclosure of potential conflict of interest: K. Hannula-Jouppi has been supported by Helsinki University Hospital Research Funds (grant no. TYH2013235), has received travel support from the Finnish Dermatology Society, and has received travel support from the Finnish Dermatology Society and Jannsen-Cilaq. N. Kluger has been supported by grant the Helsinki University Central Hospital Research Funds (grant no. TYH2013235). S. Mäkinen-Kiljunen has received consultancy fees, lecture fees, and travel support from Thermo Fisher Scientific. A. Ranki is a member of the Independent Data Monitoring Committee, Millennium Pharmaceuticals, and the ImmunoQure AG Advisory Board. The rest of the authors declare that they have no relevant conflicts of interest. |
Vol 134 - N° 4
P. 985-988 - octobre 2014 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?